Recent news

Archived news

The scientific cooperation between BioVentures Institute Sp. z o.o., Thermo Fisher Scientific and Department of Environmental Molecular Biotechnology, Institute for Environmental and Human Health Protection, Faculty of Chemistry, University of Gdansk, has generated new molecular tools for genetic engineering. Selected results have been published in an influential scientific journal (“Related bifunctional restriction endonuclease-methyltransferase triplets: TspDTI, Tth111II/TthHB27I and TsoI with distinct specificities.” BMC Molecular Biology, 2012, 13:13).

Research affiliation between BioVentures Institute Sp. z o.o. and Department of Hepatology and Acquired Immunodeficiency, Medical University of Warsaw (Poland) concerning novel recombinant antiviral vaccines generation strategy has been established. The cooperation has already resulted in shared grant applications and in obtaining positive experimental results in the construction of specialized DNA vectors and fusion proteins, designed for the field of applied medicine.

Long term research cooperation agreement in the field of molecular biotechnology has been signed between BioVentures Institute Sp. z o.o. and Thermo Fisher Scientific (USA; Fermentas branch, Lithuania). Thermo Fisher Scientific is a worldwide leading chemical company with revenues of $12 billion and 39,000 employees.